XML 28 R18.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Note 12 - Stock-based Compensation
9 Months Ended
Apr. 30, 2024
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

NOTE 12:

STOCK-BASED COMPENSATION

 

Stock Options

 

A continuity schedule of our outstanding stock options for the three and nine months ended April 30, 2024, is as follows:

 

  

Number of Stock

  

Weighted Average

 
  

Options

  

Exercise Price

 

Balance, July 31, 2023

  8,326,983  $1.92 

Granted

  17,500   5.04 

Exercised

  (608,182)  1.69 

Cancelled/Forfeited

  (191,259)  1.59 

Expired

  (27,000)  3.69 

Balance, October 31, 2023

  7,518,042   1.94 

Granted

  10,000   7.63 

Exercised

  (878,503)  1.45 

Balance, January 31, 2024

  6,649,539   2.01 

Granted

  40,143   6.70 

Exercised

  (406,411)  1.61 

Cancelled/Forfeited

  (8,600)  3.45 

Expired

  (25,000)  1.44 

Balance, April 30, 2024

  6,249,671   2.07 

 

The table below sets forth the number of shares issued and cash received upon exercise of our stock options:

 

  

Three Months Ended April 30,

  

Nine Months Ended April 30,

 
  

2024

  

2023

  

2024

  

2023

 

Number of Options Exercised on Cash Basis

  202,437   -   492,112   138,537 

Number of Options Exercised on Forfeiture Basis

  203,974   337,500   1,400,984   2,727,295 

Total Number of Options Exercised

  406,411   337,500   1,893,096   2,865,832 

Number of Shares Issued on Cash Exercise

  202,437   -   492,112   138,537 

Number of Shares Issued on Forfeiture Basis

  142,640   204,693   968,825   1,565,059 

Total Number of Shares Issued Upon Exercise of Options

  345,077   204,693   1,460,937   1,703,596 

Cash Received from Exercise of Stock Options

 $281  $-  $681  $206 

Total Intrinsic Value of Options Exercised

 $2,431  $858  $9,022  $6,834 

  

 

A continuity schedule of our outstanding unvested stock options as of April 30, 2024, and the changes during the period, is as follows:

 

 

Number of Unvested Stock Options

 

Weighted Average Grant-Date Fair Value

Balance, July 31, 2023

 1,803,265 $2.28

Granted

 17,500  3.36

Cancelled/Forfeited

 (12,300) 2.37

Vested

 (133,062) 2.18

Balance, October 31, 2023

 1,675,403  2.29

Granted

 10,000  5.05

Vested

 (429,513) 2.39

Balance, January 31, 2024

 1,255,890  2.28

Granted

 40,143  4.45

Cancelled/Forfeited

 (8,600) 2.27

Vested

 (29,687) 2.29

Balance, April 30, 2024

 1,257,746  2.35

 

For the nine months ended  April 30, 2024, the fair value of the stock options granted was estimated using the Black-Scholes model with the following assumptions, which is level 2 of the fair value measurement hierarchy:

 

Exercise Price

4.722 to7.6363

Expected Risk Free Interest Rate

3.99% to 4.67%

Expected Volatility

79.30% to 79.57%

Expected Life in Years

5

Expected Dividend Yield

0.00%

 

As at April 30, 2024, the aggregate intrinsic value of all of our outstanding stock options was estimated at $29,252 (vested: $25,374 and unvested: $3,878).  As at April 30, 2024, our unrecognized compensation cost related to unvested stock options was $1,193, which is expected to be recognized over 0.98 years.

 

A summary of our stock options outstanding and exercisable as of April 30, 2024, is as follows:

 

  

Options Outstanding

  

Options Exercisable

 
          

Weighted

          

Weighted

 
          

Average

          

Average

 

Range of

     

Weighted

  

Remaining

      

Weighted

  

Remaining

 

Exercise

 

Outstanding at

  

Average

  

Contractual

  

Exercisable at

  

Average

  

Contractual

 

Prices

 

April 30, 2024

  

Exercise Price

  

Term (Years)

  

April 30, 2024

  

Exercise Price

  

Term (Years)

 

$0.91 to $0.99

  2,140,500  $0.92   5.83   2,140,500  $0.92   5.83 

$1.00 to $1.99

  1,325,000   1.10   6.21   1,325,000   1.10   6.21 

$2.00 to $2.99

  537,149   2.26   7.18   537,149   2.26   7.18 

$3.00 to $3.99

  2,176,879   3.61   8.43   982,401   3.71   8.02 

$4.00 to $4.99

  7,500   4.56   9.06   2,500   4.48   8.92 

$5.00 to $5.99

  12,500   5.16   9.42   3,125   5.16   9.42 

$6.00 to $6.99

  40,143   6.70   9.89   -         

$7.00 to $7.63

  10,000   7.63   9.73   1,250   7.63   9.73 
   6,249,671  $2.07   6.98   4,991,925  $1.67   6.51 

 

 

 

Restricted Stock Units

 

A summary of our outstanding and unvested restricted stock units (“RSU”s) as of April 30, 2024, is as follows:

 

  

Number of

             
  

Restricted Stock

  

Grant Date

  

Remaining Life

  

Aggregate

 

Grant Date

 

Units

  

Fair Value

  

(Years)

  

Intrinsic Value

 

July 21, 2021

  135,875   2.15   0.31   917 

May 1, 2022

  39,216   4.25   1.09   265 

July 29, 2022

  184,023   3.98   1.33   1,242 

July 31, 2023

  620,386   3.32   2.34   4,188 

January 2, 2024

  1,166   6.44   2.76   8 

January 22, 2024

  8,919   7.63   0.82   60 

March 13, 2024

  2,288   6.49   0.95   15 

April 1, 2024

  20,000   7.07   3.00   135 
   1,011,873  $3.44   1.83  $6,830 

 

During the three and nine months ended April 30, 2024, our stock-based compensation related to RSUs was $453 and $1,326 (three and nine months ended April 30, 2023: $283 and $869), respectively.  As at April 30, 2024, our unrecognized compensation costs related to unvested RSUs totaled $1,562, which is expected to be recognized over a period of approximately 1.46 years.

 

Performance Based Restricted Stock Units

 

During the three and nine months ended April 30, 2024, our stock-based compensation related to the amortization of target performance based restricted stock units (“PRSU”s) totaled $176 and $529 (three and nine months ended April 30, 2023: $99 and $298), respectively.  As at April 30, 2024, our unrecognized compensation costs relating to unvested PRSUs totaled $978, which is expected to be recognized over a period of approximately 1.93 years.

 

Stock-Based Compensation

 

A summary of our stock-based compensation expense as of April 30, 2024, is as follows:

 

  

Three Months Ended

  

Nine Months Ended

 
  

April 30,

  

April 30,

 
  

2024

  

2023

  

2024

  

2023

 

Stock-Based Compensation for Consultants

                

Common stock issued to consultants

 $-  $107  $-  $382 

Amortization of stock option expenses

  87   95   302   467 
   87   202   302   849 

Stock-Based Compensation for Management

                

Amortization of stock option expenses

  120   95   488   323 

Amortization of RSU and PRSU expenses

  585   346   1,774   1,053 
   705   441   2,262   1,376 

Stock-Based Compensation for Employees

                

Common stock issued to employees

  -   188   -   675 

Amortization of stock option expenses

  285   314   1,362   1,441 

Amortization of RSU expenses

  26   37   61   114 
   311   539   1,423   2,230 
  $1,103  $1,182  $3,987  $4,455